Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company OxThera AB
DescriptionRecombinant oxalate decarboxylase
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard IndicationHyperoxaluria
Indication DetailsPrevent oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today